- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Kelsey Natsuhara, MD
She | Her | HersBreast Medical Oncology- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Kelsey Natsuhara, MD
She | Her | HersBreast Medical Oncology- Accepting New Patients
- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Kelsey Natsuhara is a medical oncologist who specializes in caring for patients with breast cancer. She has expertise in addressing all stages of the disease.
In her research, Natsuhara studies cancer care delivery, focusing on improving access to high-quality care and clinical trials (studies of promising treatments) through digital tools, such as telehealth. She also has an interest in clinical informatics, using large real-world datasets to study outcomes for patients with cancer. She received a Young Investigator Award from the American Society of Clinical Oncology (ASCO) for her telehealth work and serves on the ASCO Trainee and Early Career Advisory Group.
Natsuhara earned her medical degree at Harvard Medical School. She completed a residency in internal medicine and a fellowship in hematology-oncology at UCSF, serving as both chief resident and chief fellow.
Education & training
Board certification
- Medical Oncology, American Board of Internal Med/Medical Oncology
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, UCSF Graduate Medical Education
Internship
- Internal Medicine, UCSF Graduate Medical Education
Degree
- MD, Harvard Medical School
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%223115%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223115%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.